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EDITORIAL:	  
Screening	  mammography	  requires	  
informed	  consent	  
JAMES	  P.	  MEZA,	  MD,	  PhD,	  Wayne	  State	  University	  School	  of	  Medicine	  
	  
One	  day	  I	  was	  describing	  how	  health	  systems	  ignore	  research	  evidence	  and	  harm	  patients,	  asking	  out	  loud,	  “Where	  are	  all	  the	  
doctors?”	  One	  of	  my	  colleagues	  said,	  “I	  don’t	  understand	  why	  doctors	  don’t	  say	  anything.”	  A	  different	  colleague	  replied,	  “That’s	  
easy—they	  don’t	  want	  to	  get	  fired.”	  I	  know	  from	  personal	  experience	  that	  my	  colleagues	  were	  describing	  reality.	  As	  a	  social	  scientist,	  
I	  know	  the	  cultural	  values,	  political	  economy,	  and	  sociocultural	  theories	  to	  explain	  why	  doctors	  are	  afraid	  to	  speak	  the	  truth	  about	  
evidence-­‐based	  medicine,	  even	  though	  they	  acknowledge	  patients	  suffer	  the	  burden.	  	  
Medical	  students	  also	  bear	  the	  burden	  of	  this	  cultural	  dynamic.	  In	  my	  many	  years	  as	  a	  medical	  educator,	  I	  have	  learned	  to	  follow	  a	  
few	  simple	  rules,	  one	  of	  which	  is	  to	  never	  ask	  a	  medical	  student	  or	  resident	  to	  do	  something	  that	  I	  would	  personally	  never	  do	  myself.	  
My	  job	  is	  not	  only	  to	  teach,	  but	  also	  to	  create	  a	  learning	  environment	  where	  individuals	  maximize	  their	  potential,	  which	  requires	  
humility	  and	  a	  sense	  of	  intimacy,	  trust	  and	  safety.	  During	  one	  of	  my	  small	  group	  sessions	  with	  first	  year	  medical	  students,	  a	  student	  
stood	  up	  in	  front	  of	  his	  classmates,	  looked	  at	  me	  and	  said:	  “Dr.	  Meza,	  your	  generation	  of	  doctors	  [expletive	  deleted]-­‐up	  medicine	  
and	  my	  generation	  of	  doctors	  has	  to	  pay	  the	  price.”	  I	  looked	  back	  at	  him	  and	  said,	  “You’re	  right.”	  	  
At	  the	  Wayne	  State	  University	  School	  of	  Medicine	  white	  coat	  ceremony	  in	  2013,	  I	  said:	  “A	  student	  from	  the	  Gold	  Humanism	  Honor	  
Society	  asked	  me	  what	  I	  wanted	  to	  tell	  her	  generation	  of	  doctors.	  I	  replied,	  ‘I	  want	  the	  next	  generation	  of	  doctors	  to	  find	  it’s	  voice—
society	  needs	  you.’”	  I	  have	  been	  feeling	  guilty	  ever	  since	  I	  made	  that	  comment	  because	  I	  broke	  my	  own	  rule.	  Of	  course,	  I	  am	  scared	  
to	  speak	  truth	  to	  power,	  but	  the	  student	  contributors	  to	  this	  first	  issue	  of	  Clinical	  Research	  in	  Practice:	  The	  Journal	  of	  Team	  
Hippocrates	  have	  demonstrated	  the	  courage	  necessary	  to	  heal	  society,	  healthcare,	  and	  provide	  exemplary	  care	  for	  their	  patients.	  
See	  the	  above	  reflection	  by	  Stephen	  Simmer.	  	  
So,	  here	  is	  my	  confession:	  the	  Healthcare	  Effectiveness	  Data	  and	  Information	  Set	  (HEDIS)	  published	  by	  the	  National	  Committee	  for	  
Quality	  Assurance	  (NCQA),	  the	  Center	  for	  Medicare	  Services	  (CMS),	  Accountable	  Care	  Organizations	  (ACO),	  and	  commercial	  
insurance	  agencies	  establish	  reimbursement	  plans	  and	  define	  quality	  standards	  including	  recommendations	  for	  screening	  
mammography1,2.	  Yet,	  the	  Nordic	  Cochrane	  Centre	  leaflet	  “Screening	  for	  Breast	  Cancer	  with	  Mammography”	  makes	  the	  following	  
comment	  regarding	  screening	  mammography:	  “It	  therefore	  no	  longer	  seems	  beneficial	  to	  attend	  for	  breast	  cancer	  screening…	  
Screening	  does	  not	  reduce	  the	  overall	  risk	  of	  dying,	  or	  the	  overall	  risk	  of	  dying	  from	  cancer	  (including	  breast	  cancer)”3.	  For	  those	  
women	  who	  are	  over-­‐diagnosed,	  Cochrane	  further	  states:	  “Screening	  produces	  patients	  with	  breast	  cancer	  from	  among	  healthy	  
women	  who	  would	  never	  have	  developed	  symptoms	  of	  breast	  cancer.	  Treatment	  of	  these	  healthy	  women	  increases	  their	  risk	  of	  
dying,	  e.g.	  from	  heart	  disease	  and	  cancer”3.	  Cochrane	  produces	  the	  highest	  standard	  of	  evidence-­‐based	  review.	  It	  bothers	  me	  that	  
doctors	  are	  not	  more	  aware	  of	  the	  jarring	  inconsistency	  of	  guidelines	  and	  incentives	  with	  evidence.	  Other	  countries	  have	  made	  
adjustments	  to	  medical	  practice:	  The	  Swiss	  medical	  board	  also	  found	  no	  evidence	  to	  suggest	  that	  screening	  mammography	  reduced	  
overall	  mortality4.	  We	  are	  now	  at	  the	  one	  year	  anniversary	  of	  the	  publication	  of	  more	  high	  quality	  evidence	  that	  magnifies	  the	  
inconsistencies	  between	  the	  medical	  research	  literature	  and	  clinical	  practice	  guidelines:	  the	  twenty	  five	  year	  follow-­‐up	  for	  breast	  
cancer	  incidence	  and	  mortality	  of	  the	  Canadian	  National	  Breast	  Screening	  Study,	  a	  randomized	  screening	  trial	  that	  confirms	  the	  
 
MEZA	  JP.	  Screening	  mammography	  requires	  patient	  consent. VOL 1 ISS 1 / eP1027 / JAN-MAR 2015 	  
	  
	  
http://digitalcommons.wayne.edu/crp,	  ©	  2015	  The	  Author(s)	  
2	   Licensed	  under	  Creative	  Commons	  Attribution	  Non-­‐Commercial	  4.0	  
	  
above	  Cochrane	  summary	  through	  its	  conclusion	  that	  in	  the	  current	  clinical	  context,	  screening	  mammography	  does	  not	  reduce	  
mortality5.	  
	  This	  evidence	  calls	  into	  question	  the	  definition	  of	  quality	  care.	  The	  clinical	  epidemiology	  of	  overdiagnosis	  means	  that	  providing	  what	  
we	  currently	  label	  “quality	  care”	  will	  worsen	  health	  outcomes.	  Yet,	  physician	  and	  healthcare	  institutional	  financial	  incentives	  
contradict	  what	  the	  available	  evidence	  tells	  me	  is	  in	  the	  best	  interest	  of	  my	  patient.	  In	  the	  privacy	  of	  the	  exam	  room,	  I	  share	  the	  
evidence	  with	  my	  patients	  and	  allow	  them	  to	  decide	  what	  is	  best	  for	  them.	  This	  reinforces	  Gordan	  Guyatt’s	  statement,	  which	  is	  
found	  on	  this	  journal’s	  website	  that	  “different	  patients	  use	  the	  same	  evidence	  differently.”	  Obviously,	  different	  doctors	  interpret	  
evidence	  differently,	  but	  at	  a	  minimum	  I	  ask	  my	  colleagues	  to	  “join	  the	  conversation”	  at	  grand	  rounds,	  in	  hallway	  conversations,	  or	  
online	  at	  websites	  like	  http://theconversation.com/us.	  	  	  
This	  is	  an	  open	  letter	  to	  all	  medical	  directors	  of	  insurance	  companies	  and	  healthcare	  organizations.	  You	  were	  doctors	  before	  you	  
became	  physician	  administrators	  and	  I	  ask	  you	  to	  heed	  the	  oath	  from	  this	  journal’s	  namesake:	  “I	  will	  willingly	  refrain	  from	  doing	  any	  
injury	  or	  wrong	  from	  falsehood…”	  My	  generation	  of	  doctors	  owes	  it	  to	  those	  that	  come	  after	  us	  to	  teach	  by	  our	  actions,	  not	  our	  
words.	  The	  students	  that	  make	  this	  journal	  possible	  deserve	  nothing	  less.	  This	  editorial	  is	  reflective	  of	  my	  opinion,	  however,	  as	  an	  
educator,	  if	  I	  ask	  medical	  students	  to	  use	  their	  voices,	  I	  am	  obligated	  to	  use	  mine.	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